403 related articles for article (PubMed ID: 16314472)
1. Transforming growth factor-beta regulation of epithelial tight junction proteins enhances barrier function and blocks enterohemorrhagic Escherichia coli O157:H7-induced increased permeability.
Howe KL; Reardon C; Wang A; Nazli A; McKay DM
Am J Pathol; 2005 Dec; 167(6):1587-97. PubMed ID: 16314472
[TBL] [Abstract][Full Text] [Related]
2. Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function.
Johnson-Henry KC; Donato KA; Shen-Tu G; Gordanpour M; Sherman PM
Infect Immun; 2008 Apr; 76(4):1340-8. PubMed ID: 18227169
[TBL] [Abstract][Full Text] [Related]
3. Escherichia albertii and Hafnia alvei are candidate enteric pathogens with divergent effects on intercellular tight junctions.
Donato KA; Zareie M; Jassem AN; Jandu N; Alingary N; Carusone SC; Johnson-Henry KC; Sherman PM
Microb Pathog; 2008; 45(5-6):377-85. PubMed ID: 18930803
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of Lactobacillus plantarum on epithelial barrier disruption caused by enterotoxigenic Escherichia coli in intestinal porcine epithelial cells.
Wu Y; Zhu C; Chen Z; Chen Z; Zhang W; Ma X; Wang L; Yang X; Jiang Z
Vet Immunol Immunopathol; 2016 Apr; 172():55-63. PubMed ID: 27032504
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta induces epithelial to mesenchymal transition by down-regulation of claudin-1 expression and the fence function in adult rat hepatocytes.
Kojima T; Takano K; Yamamoto T; Murata M; Son S; Imamura M; Yamaguchi H; Osanai M; Chiba H; Himi T; Sawada N
Liver Int; 2008 Apr; 28(4):534-45. PubMed ID: 18031476
[TBL] [Abstract][Full Text] [Related]
6. Differing roles of protein kinase C-zeta in disruption of tight junction barrier by enteropathogenic and enterohemorrhagic Escherichia coli.
Tomson FL; Koutsouris A; Viswanathan VK; Turner JR; Savkovic SD; Hecht G
Gastroenterology; 2004 Sep; 127(3):859-69. PubMed ID: 15362041
[TBL] [Abstract][Full Text] [Related]
7. Enterohemorrhagic E. coli alters murine intestinal epithelial tight junction protein expression and barrier function in a Shiga toxin independent manner.
Roxas JL; Koutsouris A; Bellmeyer A; Tesfay S; Royan S; Falzari K; Harris A; Cheng H; Rhee KJ; Hecht G
Lab Invest; 2010 Aug; 90(8):1152-68. PubMed ID: 20479715
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles and soluble factors secreted by Escherichia coli Nissle 1917 and ECOR63 protect against enteropathogenic E. coli-induced intestinal epithelial barrier dysfunction.
Alvarez CS; Giménez R; Cañas MA; Vera R; Díaz-Garrido N; Badia J; Baldomà L
BMC Microbiol; 2019 Jul; 19(1):166. PubMed ID: 31315566
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta3 perturbs the inter-Sertoli tight junction permeability barrier in vitro possibly mediated via its effects on occludin, zonula occludens-1, and claudin-11.
Lui WY; Lee WM; Cheng CY
Endocrinology; 2001 May; 142(5):1865-77. PubMed ID: 11316752
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β1 protects against intestinal epithelial barrier dysfunction caused by hypoxia-reoxygenation.
Howe KL; Lorentz RJ; Assa A; Pinnell LJ; Johnson-Henry KC; Sherman PM
Shock; 2015 May; 43(5):483-9. PubMed ID: 25608140
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes.
Grände M; Franzen A; Karlsson JO; Ericson LE; Heldin NE; Nilsson M
J Cell Sci; 2002 Nov; 115(Pt 22):4227-36. PubMed ID: 12376555
[TBL] [Abstract][Full Text] [Related]
12. Role for TGF-beta in cyclosporine-induced modulation of renal epithelial barrier function.
Feldman G; Kiely B; Martin N; Ryan G; McMorrow T; Ryan MP
J Am Soc Nephrol; 2007 Jun; 18(6):1662-71. PubMed ID: 17460148
[TBL] [Abstract][Full Text] [Related]
13. Enterohemorrhagic Escherichia coli O157 outer membrane vesicles induce interleukin 8 production in human intestinal epithelial cells by signaling via Toll-like receptors TLR4 and TLR5 and activation of the nuclear factor NF-κB.
Bielaszewska M; Marejková M; Bauwens A; Kunsmann-Prokscha L; Mellmann A; Karch H
Int J Med Microbiol; 2018 Oct; 308(7):882-889. PubMed ID: 29934223
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction pathways involved in enterohemorrhagic Escherichia coli-induced alterations in T84 epithelial permeability.
Philpott DJ; McKay DM; Mak W; Perdue MH; Sherman PM
Infect Immun; 1998 Apr; 66(4):1680-7. PubMed ID: 9529098
[TBL] [Abstract][Full Text] [Related]
15. Claudins regulate the intestinal barrier in response to immune mediators.
Kinugasa T; Sakaguchi T; Gu X; Reinecker HC
Gastroenterology; 2000 Jun; 118(6):1001-11. PubMed ID: 10833473
[TBL] [Abstract][Full Text] [Related]
16. Cathelicidin-WA Improves Intestinal Epithelial Barrier Function and Enhances Host Defense against Enterohemorrhagic Escherichia coli O157:H7 Infection.
Yi H; Hu W; Chen S; Lu Z; Wang Y
J Immunol; 2017 Feb; 198(4):1696-1705. PubMed ID: 28062699
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-18 facilitates neutrophil transmigration via myosin light chain kinase-dependent disruption of occludin, without altering epithelial permeability.
Lapointe TK; Buret AG
Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G343-51. PubMed ID: 22135309
[TBL] [Abstract][Full Text] [Related]
18. Aspirin induces gastric epithelial barrier dysfunction by activating p38 MAPK via claudin-7.
Oshima T; Miwa H; Joh T
Am J Physiol Cell Physiol; 2008 Sep; 295(3):C800-6. PubMed ID: 18667601
[TBL] [Abstract][Full Text] [Related]
19. Role of EHEC O157:H7 virulence factors in the activation of intestinal epithelial cell NF-kappaB and MAP kinase pathways and the upregulated expression of interleukin 8.
Berin MC; Darfeuille-Michaud A; Egan LJ; Miyamoto Y; Kagnoff MF
Cell Microbiol; 2002 Oct; 4(10):635-48. PubMed ID: 12366401
[TBL] [Abstract][Full Text] [Related]
20. Bacillus amyloliquefaciens TL106 protects mice against enterohaemorrhagic Escherichia coli O157:H7-induced intestinal disease through improving immune response, intestinal barrier function and gut microbiota.
Bao CL; Liu SZ; Shang ZD; Liu YJ; Wang J; Zhang WX; Dong B; Cao YH
J Appl Microbiol; 2021 Jul; 131(1):470-484. PubMed ID: 33289241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
